Skip to content

Clinical trials

Neuroectodermal Tumors trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neuroectodermal Tumors Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20083
20092
20102
20121
20141
20151
20163
20173
20192
20202
20211
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Unknown status5
Recruiting4
Terminated2
Approved for marketing1
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)3
DNAtrix, Inc.2
M.D. Anderson Cancer Center2
Assistance Publique - Hôpitaux de Paris1
BeiGene USA, Inc.1
Beijing Tiantan Hospital1
Boehringer Ingelheim1
Gradalis, Inc.1
Hoffmann-La Roche1
Jazz Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neuroectodermal Tumors28
Neoplasms15
Glioma12
Neoplasms, Nerve Tissue11
Neoplasms by Histologic Type10
Neoplasms, Germ Cell and Embryonal9
Brain Neoplasms8
Glioblastoma8
Neoplasms, Neuroepithelial8
Central Nervous System Neoplasms7

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.